Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pancreatitis | 7 | 2023 | 1087 | 1.710 |
Why?
|
Gastrointestinal Hemorrhage | 13 | 2021 | 1126 | 1.650 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 7 | 2023 | 520 | 1.440 |
Why?
|
Intestinal Polyposis | 3 | 2021 | 42 | 1.040 |
Why?
|
Esophagitis | 8 | 2008 | 164 | 1.020 |
Why?
|
Adenomatous Polyposis Coli | 2 | 2022 | 219 | 0.880 |
Why?
|
Endoscopy, Gastrointestinal | 9 | 2024 | 888 | 0.810 |
Why?
|
Eosinophilia | 7 | 2008 | 556 | 0.780 |
Why?
|
Gastrointestinal Diseases | 8 | 2018 | 1206 | 0.730 |
Why?
|
Neoplastic Syndromes, Hereditary | 2 | 2021 | 249 | 0.700 |
Why?
|
Capsule Endoscopy | 2 | 2019 | 106 | 0.690 |
Why?
|
Propofol | 2 | 2021 | 608 | 0.680 |
Why?
|
Esophageal and Gastric Varices | 2 | 2019 | 215 | 0.670 |
Why?
|
Deep Sedation | 1 | 2021 | 119 | 0.670 |
Why?
|
Colonic Polyps | 2 | 2022 | 557 | 0.620 |
Why?
|
Esophagus | 7 | 2018 | 1042 | 0.600 |
Why?
|
Hypertension, Portal | 1 | 2019 | 230 | 0.570 |
Why?
|
Dexmedetomidine | 1 | 2021 | 320 | 0.540 |
Why?
|
Rhabdomyosarcoma | 1 | 2018 | 358 | 0.480 |
Why?
|
Pluripotent Stem Cells | 4 | 2013 | 809 | 0.470 |
Why?
|
Embryonic Stem Cells | 6 | 2013 | 1250 | 0.460 |
Why?
|
Vascular Malformations | 2 | 2018 | 469 | 0.460 |
Why?
|
Eosinophils | 4 | 2008 | 952 | 0.440 |
Why?
|
Analgesia | 1 | 2018 | 460 | 0.430 |
Why?
|
Child | 52 | 2024 | 80917 | 0.410 |
Why?
|
Conscious Sedation | 2 | 2008 | 534 | 0.410 |
Why?
|
Sirolimus | 1 | 2019 | 1540 | 0.400 |
Why?
|
Endoscopy | 3 | 2017 | 1854 | 0.380 |
Why?
|
Analgesics | 1 | 2018 | 1071 | 0.360 |
Why?
|
Nevus, Blue | 3 | 2005 | 43 | 0.350 |
Why?
|
Glass | 1 | 2011 | 116 | 0.350 |
Why?
|
Arteriovenous Malformations | 2 | 2005 | 396 | 0.350 |
Why?
|
Gastroscopy | 2 | 2005 | 213 | 0.340 |
Why?
|
Hemangioma | 5 | 2018 | 727 | 0.310 |
Why?
|
Endosonography | 3 | 2017 | 626 | 0.300 |
Why?
|
Child, Preschool | 31 | 2024 | 42669 | 0.290 |
Why?
|
Cell Culture Techniques | 3 | 2013 | 1667 | 0.280 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4206 | 0.260 |
Why?
|
Midazolam | 1 | 2008 | 267 | 0.260 |
Why?
|
Barrett Esophagus | 2 | 2020 | 495 | 0.260 |
Why?
|
Capnography | 1 | 2006 | 90 | 0.250 |
Why?
|
Cautery | 1 | 2005 | 73 | 0.240 |
Why?
|
Cutaneous Fistula | 1 | 2005 | 79 | 0.240 |
Why?
|
Duodenoscopes | 2 | 2022 | 43 | 0.240 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2006 | 169 | 0.240 |
Why?
|
Gastric Fistula | 1 | 2005 | 73 | 0.240 |
Why?
|
Fentanyl | 1 | 2008 | 451 | 0.230 |
Why?
|
Esophagoscopy | 4 | 2003 | 398 | 0.230 |
Why?
|
Adolescent | 30 | 2022 | 89169 | 0.230 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2015 | 957 | 0.220 |
Why?
|
Duodenum | 2 | 2004 | 495 | 0.210 |
Why?
|
Receptors, Notch | 1 | 2007 | 751 | 0.210 |
Why?
|
Mitochondrial Encephalomyopathies | 1 | 2002 | 40 | 0.200 |
Why?
|
Colectomy | 3 | 2022 | 696 | 0.200 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6974 | 0.200 |
Why?
|
Choledochal Cyst | 1 | 2022 | 25 | 0.200 |
Why?
|
Digestive System Abnormalities | 1 | 2001 | 49 | 0.190 |
Why?
|
Thoracoscopy | 2 | 2018 | 186 | 0.190 |
Why?
|
Abdominal Pain | 2 | 2018 | 1070 | 0.190 |
Why?
|
Esophageal Achalasia | 2 | 2018 | 98 | 0.190 |
Why?
|
Intestines | 3 | 2009 | 1909 | 0.180 |
Why?
|
Humans | 79 | 2024 | 768166 | 0.180 |
Why?
|
Short Bowel Syndrome | 1 | 2024 | 352 | 0.180 |
Why?
|
Cell Communication | 1 | 2007 | 1660 | 0.180 |
Why?
|
Syndrome | 3 | 2022 | 3272 | 0.170 |
Why?
|
Gallbladder | 1 | 2022 | 308 | 0.170 |
Why?
|
Pancreatic Neoplasms | 1 | 2018 | 5446 | 0.170 |
Why?
|
Pediatrics | 4 | 2017 | 3629 | 0.170 |
Why?
|
Gastrostomy | 2 | 2005 | 325 | 0.160 |
Why?
|
Pancreatic Diseases | 2 | 2017 | 354 | 0.150 |
Why?
|
Maple Syrup Urine Disease | 1 | 2018 | 41 | 0.150 |
Why?
|
Colonic Neoplasms | 1 | 2010 | 2541 | 0.150 |
Why?
|
Endoscopy, Digestive System | 2 | 1998 | 358 | 0.150 |
Why?
|
Stomach | 1 | 2002 | 701 | 0.150 |
Why?
|
Infant | 18 | 2024 | 36535 | 0.150 |
Why?
|
Gastroesophageal Reflux | 4 | 2020 | 836 | 0.140 |
Why?
|
Retrospective Studies | 16 | 2024 | 81762 | 0.140 |
Why?
|
Imaging, Three-Dimensional | 1 | 2011 | 4063 | 0.140 |
Why?
|
Catheterization | 1 | 2022 | 1430 | 0.140 |
Why?
|
Colonoscopy | 2 | 2022 | 1409 | 0.140 |
Why?
|
Portal Vein | 2 | 2010 | 435 | 0.140 |
Why?
|
Female | 44 | 2024 | 397192 | 0.140 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2017 | 100 | 0.130 |
Why?
|
Hemostasis, Surgical | 1 | 1996 | 128 | 0.130 |
Why?
|
Cell Differentiation | 4 | 2013 | 11669 | 0.120 |
Why?
|
Pancreas | 2 | 2017 | 1700 | 0.120 |
Why?
|
Intestine, Small | 2 | 2024 | 1217 | 0.120 |
Why?
|
Acute Disease | 3 | 2023 | 7243 | 0.120 |
Why?
|
Rectum | 3 | 2010 | 900 | 0.120 |
Why?
|
Prospective Studies | 9 | 2022 | 54926 | 0.120 |
Why?
|
Thyroid Nodule | 1 | 2022 | 767 | 0.120 |
Why?
|
Esophagitis, Peptic | 2 | 2006 | 77 | 0.120 |
Why?
|
Cell Lineage | 1 | 2003 | 2575 | 0.120 |
Why?
|
Male | 39 | 2024 | 364719 | 0.110 |
Why?
|
Embryoid Bodies | 1 | 2013 | 66 | 0.110 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2014 | 115 | 0.110 |
Why?
|
Surface Properties | 2 | 2011 | 1166 | 0.110 |
Why?
|
Hypnotics and Sedatives | 1 | 2021 | 1191 | 0.100 |
Why?
|
Feasibility Studies | 2 | 2024 | 5315 | 0.100 |
Why?
|
Polyglycolic Acid | 1 | 2013 | 408 | 0.100 |
Why?
|
Skin Neoplasms | 4 | 2015 | 5863 | 0.100 |
Why?
|
Diagnosis, Differential | 6 | 2018 | 13014 | 0.100 |
Why?
|
Embryo, Mammalian | 2 | 2011 | 1676 | 0.100 |
Why?
|
Follow-Up Studies | 7 | 2020 | 39348 | 0.090 |
Why?
|
Culture Media, Serum-Free | 1 | 2011 | 148 | 0.090 |
Why?
|
Adult | 15 | 2022 | 223646 | 0.090 |
Why?
|
Colony-Forming Units Assay | 1 | 2011 | 351 | 0.090 |
Why?
|
Stem Cell Niche | 1 | 2013 | 347 | 0.090 |
Why?
|
Acids | 1 | 2011 | 125 | 0.090 |
Why?
|
bcl-X Protein | 1 | 2011 | 412 | 0.090 |
Why?
|
Sterilization | 1 | 2011 | 132 | 0.090 |
Why?
|
Mesenteric Veins | 1 | 2010 | 87 | 0.080 |
Why?
|
Matrix Metalloproteinase 2 | 2 | 2009 | 461 | 0.080 |
Why?
|
Growth | 1 | 2011 | 366 | 0.080 |
Why?
|
Deoxyribonucleases | 1 | 2011 | 209 | 0.080 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1989 | 40 | 0.080 |
Why?
|
Infant, Newborn | 9 | 2017 | 26422 | 0.080 |
Why?
|
Metaplasia | 2 | 2020 | 326 | 0.080 |
Why?
|
Biopsy | 3 | 2020 | 6793 | 0.080 |
Why?
|
Veins | 2 | 2006 | 769 | 0.080 |
Why?
|
Ligation | 3 | 2010 | 446 | 0.080 |
Why?
|
Signal Transduction | 2 | 2013 | 23645 | 0.080 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2009 | 633 | 0.080 |
Why?
|
Receptors, CCR5 | 1 | 2011 | 491 | 0.080 |
Why?
|
Thyroid Neoplasms | 1 | 2022 | 2360 | 0.080 |
Why?
|
Lactic Acid | 1 | 2013 | 1140 | 0.080 |
Why?
|
Deglutition Disorders | 3 | 2004 | 640 | 0.080 |
Why?
|
Fluoroscopy | 2 | 2023 | 947 | 0.080 |
Why?
|
Esophagogastric Junction | 2 | 2020 | 351 | 0.070 |
Why?
|
Carcinoma, Embryonal | 1 | 2007 | 36 | 0.070 |
Why?
|
Lymphatic Abnormalities | 1 | 2009 | 134 | 0.070 |
Why?
|
Anesthesia Recovery Period | 1 | 2008 | 155 | 0.070 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4912 | 0.070 |
Why?
|
Colon | 2 | 2009 | 1801 | 0.070 |
Why?
|
Tissue Scaffolds | 1 | 2013 | 951 | 0.070 |
Why?
|
Protein Transport | 2 | 2013 | 1951 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2536 | 0.070 |
Why?
|
Liver | 3 | 2003 | 7577 | 0.060 |
Why?
|
Lymphangioma | 1 | 2006 | 60 | 0.060 |
Why?
|
Matrix Metalloproteinases | 1 | 2008 | 393 | 0.060 |
Why?
|
Autoimmune Diseases | 1 | 2018 | 2257 | 0.060 |
Why?
|
Angiomatosis | 1 | 2005 | 46 | 0.060 |
Why?
|
Ambulatory Care | 1 | 1996 | 2783 | 0.060 |
Why?
|
Anesthetics, Intravenous | 1 | 2008 | 397 | 0.060 |
Why?
|
Embolism, Air | 1 | 2005 | 110 | 0.060 |
Why?
|
Phosphoproteins | 1 | 2013 | 2451 | 0.060 |
Why?
|
Sampling Studies | 1 | 2005 | 615 | 0.060 |
Why?
|
Health Policy | 1 | 1996 | 2698 | 0.060 |
Why?
|
Cholanes | 1 | 2003 | 1 | 0.060 |
Why?
|
Genetic Testing | 2 | 2014 | 3591 | 0.060 |
Why?
|
Hospitals, Pediatric | 2 | 2015 | 1876 | 0.050 |
Why?
|
Endoscopes, Gastrointestinal | 2 | 2002 | 45 | 0.050 |
Why?
|
Treatment Outcome | 9 | 2019 | 65371 | 0.050 |
Why?
|
Atrioventricular Node | 1 | 2004 | 180 | 0.050 |
Why?
|
Cells, Cultured | 2 | 2011 | 19015 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 1991 | 2568 | 0.050 |
Why?
|
Foreign Bodies | 1 | 2008 | 403 | 0.050 |
Why?
|
Antigens, Surface | 1 | 2007 | 1617 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2013 | 2909 | 0.050 |
Why?
|
Hospitals, Teaching | 1 | 2008 | 1157 | 0.050 |
Why?
|
Infusions, Intravenous | 1 | 2008 | 2230 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11244 | 0.050 |
Why?
|
Recurrence | 3 | 2010 | 8509 | 0.050 |
Why?
|
RNA-Binding Proteins | 1 | 2011 | 1890 | 0.050 |
Why?
|
Epoxide Hydrolases | 1 | 2003 | 122 | 0.050 |
Why?
|
Omeprazole | 1 | 2023 | 106 | 0.050 |
Why?
|
Probability | 1 | 2008 | 2479 | 0.050 |
Why?
|
Heart Block | 1 | 2004 | 390 | 0.050 |
Why?
|
Cardia | 1 | 2002 | 61 | 0.050 |
Why?
|
Incidence | 4 | 2010 | 21538 | 0.050 |
Why?
|
PTEN Phosphohydrolase | 2 | 2021 | 1120 | 0.050 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2862 | 0.050 |
Why?
|
Gastric Mucosa | 2 | 2022 | 602 | 0.050 |
Why?
|
Clinical Competence | 1 | 1998 | 4858 | 0.050 |
Why?
|
Length of Stay | 3 | 2018 | 6498 | 0.050 |
Why?
|
Parenteral Nutrition, Total | 1 | 2002 | 304 | 0.050 |
Why?
|
Cell Survival | 2 | 2010 | 5777 | 0.050 |
Why?
|
Ubiquinone | 1 | 2002 | 181 | 0.050 |
Why?
|
Bone Morphogenetic Protein Receptors, Type I | 1 | 2021 | 97 | 0.050 |
Why?
|
Bile Acids and Salts | 1 | 2003 | 398 | 0.050 |
Why?
|
Intraoperative Complications | 2 | 2005 | 1171 | 0.050 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 3772 | 0.040 |
Why?
|
Venous Thrombosis | 1 | 2010 | 1323 | 0.040 |
Why?
|
Monitoring, Physiologic | 2 | 2006 | 1798 | 0.040 |
Why?
|
Embolization, Therapeutic | 1 | 2010 | 1402 | 0.040 |
Why?
|
Androstadienes | 1 | 2002 | 348 | 0.040 |
Why?
|
Device Removal | 1 | 2005 | 643 | 0.040 |
Why?
|
Young Adult | 4 | 2023 | 60066 | 0.040 |
Why?
|
Fibroblasts | 1 | 2011 | 4176 | 0.040 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2004 | 881 | 0.040 |
Why?
|
Ischemia | 1 | 2009 | 1900 | 0.040 |
Why?
|
North America | 2 | 2002 | 1289 | 0.040 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2011 | 1887 | 0.040 |
Why?
|
Protein Processing, Post-Translational | 1 | 2007 | 1966 | 0.040 |
Why?
|
Dicloxacillin | 1 | 1979 | 9 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2017 | 20760 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2015 | 8542 | 0.040 |
Why?
|
Biliary Tract Diseases | 1 | 2000 | 159 | 0.040 |
Why?
|
Single-Cell Analysis | 1 | 2011 | 2540 | 0.040 |
Why?
|
Intestinal Pseudo-Obstruction | 1 | 1998 | 49 | 0.040 |
Why?
|
Mitochondrial Myopathies | 1 | 1998 | 50 | 0.040 |
Why?
|
Cell Line | 5 | 2013 | 15597 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 7951 | 0.040 |
Why?
|
Point Mutation | 1 | 2003 | 1596 | 0.040 |
Why?
|
Linear Models | 1 | 2008 | 5884 | 0.040 |
Why?
|
Organic Anion Transporters, Sodium-Dependent | 1 | 1997 | 26 | 0.040 |
Why?
|
Thrombocytopenia | 1 | 2005 | 1179 | 0.040 |
Why?
|
Gastroscopes | 1 | 1997 | 20 | 0.040 |
Why?
|
Octreotide | 1 | 1998 | 156 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2007 | 3728 | 0.030 |
Why?
|
Dilatation | 1 | 2018 | 311 | 0.030 |
Why?
|
Skin Diseases | 1 | 2005 | 1085 | 0.030 |
Why?
|
Biliary Atresia | 1 | 1997 | 88 | 0.030 |
Why?
|
Cell Division | 1 | 2003 | 4473 | 0.030 |
Why?
|
Melena | 1 | 2015 | 32 | 0.030 |
Why?
|
Mice | 4 | 2013 | 82029 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 10760 | 0.030 |
Why?
|
Abdomen | 1 | 2022 | 1136 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2010 | 10474 | 0.030 |
Why?
|
Hemangioma, Cavernous | 1 | 2015 | 107 | 0.030 |
Why?
|
Animals | 7 | 2013 | 169246 | 0.030 |
Why?
|
Cellulitis | 1 | 1997 | 206 | 0.030 |
Why?
|
Mesentery | 1 | 2015 | 202 | 0.030 |
Why?
|
Sex Distribution | 1 | 2000 | 2278 | 0.030 |
Why?
|
Defibrillators, Implantable | 1 | 2004 | 1498 | 0.030 |
Why?
|
Facial Neoplasms | 1 | 2015 | 126 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12077 | 0.030 |
Why?
|
Anticoagulants | 1 | 2010 | 4852 | 0.030 |
Why?
|
Certification | 1 | 1998 | 420 | 0.030 |
Why?
|
Catheters, Indwelling | 1 | 1997 | 436 | 0.030 |
Why?
|
Symporters | 1 | 1997 | 363 | 0.030 |
Why?
|
Gastroenterology | 2 | 2002 | 593 | 0.030 |
Why?
|
Equipment Failure | 1 | 1997 | 585 | 0.030 |
Why?
|
Wound Healing | 1 | 2005 | 2809 | 0.030 |
Why?
|
Age Distribution | 1 | 2000 | 2873 | 0.030 |
Why?
|
Vitamins | 1 | 2002 | 1638 | 0.030 |
Why?
|
Esophageal Diseases | 1 | 1995 | 167 | 0.030 |
Why?
|
Sclerotherapy | 1 | 1995 | 183 | 0.030 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2008 | 2442 | 0.030 |
Why?
|
Ulcer | 1 | 1995 | 203 | 0.030 |
Why?
|
Research | 1 | 2002 | 1979 | 0.030 |
Why?
|
Gastrointestinal Agents | 1 | 1998 | 511 | 0.030 |
Why?
|
Epinephrine | 1 | 1996 | 794 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2013 | 17140 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2002 | 1805 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2021 | 2062 | 0.020 |
Why?
|
Inhibitor of Differentiation Protein 1 | 1 | 2011 | 48 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2006 | 12465 | 0.020 |
Why?
|
Equipment Design | 1 | 2000 | 3522 | 0.020 |
Why?
|
Apoptosis | 1 | 2007 | 9523 | 0.020 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2011 | 127 | 0.020 |
Why?
|
Arteries | 1 | 1996 | 1127 | 0.020 |
Why?
|
Lung | 2 | 2009 | 10099 | 0.020 |
Why?
|
Confidence Intervals | 1 | 1997 | 2923 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2007 | 9263 | 0.020 |
Why?
|
Enteral Nutrition | 1 | 1997 | 802 | 0.020 |
Why?
|
Forecasting | 1 | 2000 | 2945 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 1997 | 3436 | 0.020 |
Why?
|
Radiography | 3 | 2009 | 6983 | 0.020 |
Why?
|
Chronic Disease | 1 | 2005 | 9384 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2013 | 596 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2011 | 5902 | 0.020 |
Why?
|
Laparoscopy | 1 | 2001 | 2041 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2013 | 1524 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2013 | 1751 | 0.020 |
Why?
|
Hypersensitivity | 1 | 1999 | 1172 | 0.020 |
Why?
|
Cosmids | 1 | 1989 | 105 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2008 | 22291 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1606 | 0.020 |
Why?
|
Phlebography | 1 | 2010 | 326 | 0.020 |
Why?
|
Peritoneal Neoplasms | 1 | 2015 | 714 | 0.020 |
Why?
|
Societies, Medical | 2 | 2002 | 3968 | 0.020 |
Why?
|
Zinc Fingers | 1 | 2011 | 577 | 0.020 |
Why?
|
Restriction Mapping | 1 | 1989 | 849 | 0.020 |
Why?
|
Rhinovirus | 1 | 1970 | 209 | 0.020 |
Why?
|
DNA Probes | 1 | 1989 | 542 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1997 | 2204 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2011 | 899 | 0.020 |
Why?
|
Inflammation | 1 | 2008 | 10873 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2013 | 3590 | 0.020 |
Why?
|
Neoplasms, Second Primary | 1 | 2015 | 1061 | 0.020 |
Why?
|
Gene Targeting | 1 | 2011 | 841 | 0.020 |
Why?
|
Transgenes | 1 | 2011 | 1016 | 0.020 |
Why?
|
Surgical Wound Infection | 1 | 1997 | 1546 | 0.020 |
Why?
|
Cohort Studies | 2 | 2022 | 41754 | 0.020 |
Why?
|
Age of Onset | 1 | 2014 | 3347 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2011 | 877 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 1989 | 354 | 0.020 |
Why?
|
Reoperation | 1 | 1997 | 4329 | 0.020 |
Why?
|
Time Factors | 1 | 2008 | 40218 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2001 | 14729 | 0.020 |
Why?
|
T-Lymphocytes | 3 | 2002 | 10266 | 0.020 |
Why?
|
Anemia | 1 | 2015 | 1514 | 0.020 |
Why?
|
Cell Count | 1 | 2010 | 1832 | 0.020 |
Why?
|
Angiogenesis Inhibitors | 2 | 2006 | 2056 | 0.020 |
Why?
|
Developmental Disabilities | 1 | 2014 | 1518 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 1996 | 3044 | 0.020 |
Why?
|
RNA Interference | 1 | 2013 | 2832 | 0.020 |
Why?
|
Odds Ratio | 1 | 1997 | 9669 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2013 | 4283 | 0.010 |
Why?
|
Hemorrhage | 1 | 1996 | 3467 | 0.010 |
Why?
|
Carrier Proteins | 1 | 1997 | 4937 | 0.010 |
Why?
|
Risk Assessment | 1 | 2005 | 24315 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4580 | 0.010 |
Why?
|
Tissue Engineering | 1 | 2013 | 1893 | 0.010 |
Why?
|
Hepatocyte Nuclear Factor 3-beta | 1 | 2003 | 64 | 0.010 |
Why?
|
Genotype | 2 | 2011 | 13045 | 0.010 |
Why?
|
Pilot Projects | 2 | 2009 | 8741 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2010 | 3096 | 0.010 |
Why?
|
Celiac Disease | 1 | 1991 | 820 | 0.010 |
Why?
|
Hospitalization | 1 | 2023 | 10840 | 0.010 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2003 | 294 | 0.010 |
Why?
|
Sports | 1 | 2009 | 703 | 0.010 |
Why?
|
Liver Transplantation | 1 | 1995 | 2401 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9374 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2005 | 1703 | 0.010 |
Why?
|
Reference Values | 1 | 2009 | 4938 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2003 | 1550 | 0.010 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2004 | 582 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2011 | 3402 | 0.010 |
Why?
|
Risk Factors | 2 | 2000 | 74944 | 0.010 |
Why?
|
Electric Countershock | 1 | 2004 | 534 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 26379 | 0.010 |
Why?
|
Introns | 1 | 2003 | 966 | 0.010 |
Why?
|
Fundoplication | 1 | 2001 | 145 | 0.010 |
Why?
|
Gastritis | 1 | 2002 | 199 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2004 | 1587 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2011 | 3610 | 0.010 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2002 | 294 | 0.010 |
Why?
|
Transcription Factors | 2 | 2013 | 12168 | 0.010 |
Why?
|
Antigens, CD1 | 1 | 2002 | 434 | 0.010 |
Why?
|
Prognosis | 1 | 2000 | 30010 | 0.010 |
Why?
|
Methicillin | 1 | 1979 | 62 | 0.010 |
Why?
|
Rectal Diseases | 1 | 2000 | 142 | 0.010 |
Why?
|
Colonic Diseases | 1 | 2000 | 204 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2015 | 4887 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2004 | 2107 | 0.010 |
Why?
|
Mutation | 2 | 2013 | 30238 | 0.010 |
Why?
|
Epithelium | 1 | 2002 | 1607 | 0.010 |
Why?
|
DNA Methylation | 1 | 2011 | 4428 | 0.010 |
Why?
|
Sequence Analysis | 1 | 1997 | 240 | 0.010 |
Why?
|
Genetic Variation | 1 | 2011 | 6611 | 0.010 |
Why?
|
Neoplasms | 2 | 2013 | 22371 | 0.010 |
Why?
|
Colitis, Ulcerative | 1 | 2008 | 1926 | 0.010 |
Why?
|
Contrast Media | 1 | 2009 | 5330 | 0.010 |
Why?
|
Blotting, Western | 1 | 2003 | 5027 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2005 | 2167 | 0.010 |
Why?
|
Crohn Disease | 1 | 2008 | 2295 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2003 | 12800 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2009 | 11095 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1998 | 2560 | 0.010 |
Why?
|
Osteomyelitis | 1 | 1979 | 408 | 0.010 |
Why?
|
Antigens, CD | 1 | 2005 | 4035 | 0.010 |
Why?
|
Binding Sites | 1 | 2003 | 6020 | 0.010 |
Why?
|
Mental Disorders | 1 | 2014 | 6874 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1999 | 2486 | 0.010 |
Why?
|
Cholestasis | 1 | 1997 | 385 | 0.010 |
Why?
|
Muscles | 1 | 1998 | 1582 | 0.010 |
Why?
|
HIV-1 | 1 | 2011 | 6961 | 0.010 |
Why?
|
DNA, Mitochondrial | 1 | 1998 | 872 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2003 | 11928 | 0.010 |
Why?
|
Alleles | 1 | 2003 | 6894 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 16045 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2003 | 5797 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2008 | 15454 | 0.010 |
Why?
|
Blood Transfusion | 1 | 1998 | 1309 | 0.010 |
Why?
|
Virus Cultivation | 1 | 1970 | 88 | 0.010 |
Why?
|
Absorption | 1 | 1970 | 244 | 0.010 |
Why?
|
Immune Sera | 1 | 1970 | 605 | 0.010 |
Why?
|
Methods | 1 | 1970 | 1066 | 0.010 |
Why?
|
Culture Techniques | 1 | 1970 | 530 | 0.010 |
Why?
|
Haplorhini | 1 | 1970 | 523 | 0.010 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1991 | 897 | 0.000 |
Why?
|
Nuclear Proteins | 1 | 2003 | 5804 | 0.000 |
Why?
|
Guinea Pigs | 1 | 1970 | 1310 | 0.000 |
Why?
|
Neutralization Tests | 1 | 1970 | 739 | 0.000 |
Why?
|
Polymerase Chain Reaction | 1 | 1997 | 6082 | 0.000 |
Why?
|
Databases, Factual | 1 | 2002 | 8080 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2003 | 9615 | 0.000 |
Why?
|
Diet | 1 | 2002 | 8089 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2001 | 15948 | 0.000 |
Why?
|
Respiratory Tract Infections | 1 | 1970 | 1014 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 36743 | 0.000 |
Why?
|
Rats | 1 | 1997 | 23760 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2001 | 15832 | 0.000 |
Why?
|
Middle Aged | 2 | 2004 | 223492 | 0.000 |
Why?
|
Kidney | 1 | 1970 | 7064 | 0.000 |
Why?
|